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a b s t r a c t
The intracellular replication and molecular virulence mechanisms of Rabbit haemorrhagic disease virus
(RHDV) are poorly understood, mainly due to the lack of an effective cell culture system for this virus. To
increase our understanding of RHDV molecular biology, the subcellular localisation of recombinant non-
structural RHDV proteins was investigated in transiently transfected rabbit kidney (RK-13) cells. We
provide evidence for oligomerisation of p23, and an ability of the viral protease to cleave the p16:p23
junction in trans, outside the context of the nascent polyprotein chain. Notably, expression of the viral
polymerase alone and in the context of the entire RHDV polyprotein resulted in a redistribution of the
Golgi network. This suggests that, similar to other positive-strand RNA viruses, RHDV may recruit
membranes of the secretory pathway during replication, and that the viral polymerase may play a
critical role during this process.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Rabbit haemorrhagic disease (RHD) is a highly infectious
disease that affects wild and domestic rabbits (Oryctolagus cuni-
culus). The aetiological agent, Rabbit haemorrhagic disease virus
(RHDV), usually kills over 90% of susceptible adult animals within
48–72 h after infection (Abrantes et al., 2012). However, the
molecular mechanisms responsible for RHDV's high virulence
and the pathobiology of RHD are still poorly understood, mainly
due to the lack of a robust cell culture system for the propagation
of the virus (Abrantes et al., 2012; Clarke and Lambden, 1997).
RHDV belongs to the family Caliciviridae, genus Lagovirus
(Green et al., 2000; Ohlinger and Thiel, 1991). RHDV is a single-
stranded, positive-sense RNA virus (Abrantes et al., 2012; Meyers
et al., 1991b; Wirblich et al., 1996). The viral RNA is tightly
packaged into a non-enveloped icosahedral capsid consisting of
180 VP60 proteins (Abrantes et al., 2012; Parra and Prieto, 1990).
RHDV virions contain a 7.4 kb genomic RNA, along with a 2.1 kb
subgenomic RNA that is collinear with the 30 end of the genomic
RNA (Meyers et al., 1991a, b, 2000). Both the genomic and
subgenomic viral RNAs are polyadenylated at the 30 end and
covalently linked to a genome binding protein (VPg) at the 50
end (Abrantes et al., 2012; Machin et al., 2001; Meyers et al.,
1991a). The genomic RNA contains two slightly overlapping open
reading frames (ORFs) of approximately 7 kb (ORF1) and 351
nucleotides (ORF2), respectively (Meyers et al., 1991b; Wirblich
et al., 1996). ORF1 is translated into a large polyprotein that is
cleaved into seven non-structural proteins, i.e. p16, p23, 2C-like
helicase (p37), p29, 3C-like protease (p15), VPg (p13), RNA-
dependent RNA polymerase (p58) and the major structural (cap-
sid) protein VP60 (Martin Alonso et al., 1996; Meyers et al., 2000;
Wirblich et al., 1996). ORF2 encodes the minor structural protein
VP10 (Abrantes et al., 2012; Wirblich et al., 1996). The subgenomic
RNA encodes both structural proteins, VP60 and VP10 (Abrantes
et al., 2012; Boga et al., 1992) (Fig. 1).
The function of several RHDV proteins has been identiﬁed using
both sequence comparisons and functional studies. Sequence ana-
lysis suggests that the cleavage product, p37, of the RHDV poly-
protein is a member of the helicase superfamily III that includes
picornavirus-like (2C-like) proteins (Kadare and Haenni, 1997;
Marin et al., 2000). Recombinant RHDV p37 expressed in E. coli
showed in vitro ATP-binding and ATPase activities (Marin et al.,
2000), essential functional attributes of helicases (Kadare and
Haenni, 1997). The trypsin-like cysteine protease (p15) of RHDV is
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involved in the auto-proteolytic processing of the large viral
polyprotein encoded by ORF1. Comprising only 143 amino acids,
the RHDV enzyme is considerably smaller than 3C and 3C-like
proteases that are usually composed of more than 180 amino acids
(Wirblich et al., 1995). Nevertheless, it was shown that the RHDV
protease closely resembles the 3C proteases of picornaviruses with
respect to the amino acids in the catalytic centre (Boniotti
et al., 1994; Oka et al., 2011; Wirblich et al., 1995). The genome
binding protein VPg (p13) is covalently linked to both genomic and
subgenomic RHDV RNAs at the 50 end (Abrantes et al., 2012; Machin
et al., 2001; Meyers et al., 1991a). According to evidence obtained
for other caliciviruses, such as Feline calicivirus (FCV) (Goodfellow et
al., 2005) and human noroviruses (Daughenbaugh et al., 2003;
Goodfellow et al., 2005), it is likely that the RHDV VPg protein may
also function as a cap substitute and initiate translation through
cap-independent protein–protein interactions with the cellular
translation machinery (Daughenbaugh et al., 2003; Goodfellow et
al., 2005). Extensive sequence similarities between the 3D RNA-
dependent RNA polymerases of picornaviruses and the RHDV
polyprotein cleavage product p58 suggest that this polypeptide
has a similar role in RHDV genome replication (Lopez Vazquez et al.,
2001; Vazquez et al., 1998). Expression of the respective coding
region in E. coli showed that p58 is indeed an enzymatically active
RNA-dependent RNA polymerase (Vazquez et al., 1998). In addition
to its RNA-dependent RNA polymerase activity, p58 also catalyses
the uridylylation of VPg (Machin et al., 2001).
Very little is known about the remaining non-structural RHDV
proteins, i.e. p16, p23 and p29. While the helicase, the 3C-like
protease and the polymerase have signiﬁcant sequence and
structural homology with corresponding picornavirus proteins,
p16, p23 and p29 do not share substantial similarities with
proteins of the Picornaviridae (Meyers et al., 1991b; Wirblich
et al., 1996) or other virus families. Intracellular localisation and
function(s) of p16, p23 and p29 have not been determined to date,
and the role of these proteins in virus replication remains elusive.
Results and discussion
Subcellular localisation of individually expressed RHDV non-
structural proteins in RK-13 cells
Since the discovery of RHDV, the characterisation of its epide-
miology, genetic diversity and evolution has progressed rapidly
(Alda et al., 2010; Elsworth et al., 2014; Kerr et al., 2009; Kovaliski
et al., 2013); however, to date very little is known about viral
replication and the function of individual virus proteins, mai-
nly due to the lack of an effective cell culture system for RHDV.
Many non-structural viral proteins determine critical replication
strategies and inﬂuence host cell responses to infection. Identify-
ing the intracellular compartment in which viral proteins accu-
mulate is often the key to understanding protein functions, and
the knowledge of their subcellular localisation may even point to
possible host cell interaction partners. We therefore investigated
the subcellular localisation of all RHDV non-structural proteins
and VPg. To that end, the coding sequence of each viral protein was
fused with a C-terminal myc-tag sequence and the resulting
recombinant proteins were expressed in RK-13 cells. Cells were
ﬁxed and permeabilised 24 h after transfection, stained with myc-
tag speciﬁc antibodies and analysed using indirect immunoﬂuor-
escence techniques. We found a wide range of different localisa-
tion patterns in transfected cells expressing RHDV non-structural
proteins. While some proteins did not associate with any distinct
structures or compartments in the cells (e.g. VPg and the pro-
tease), others accumulated in particular subcellular locations (e.g.
p16, p23, the helicase, p29 and the polymerase).
The p16 protein exhibited various subcellular localisation
proﬁles. In a minority of cells (7–15% of transfected cells), p16
accumulated predominantly in the cytoplasm (Fig. 2a), but in most
cases it was either detectable in the nucleus and the cytoplasm
(39–46%; Fig. 2b), or predominantly in the nucleus (46–47%;
Fig. 2c). Intranuclear staining of p16 was also not uniform: in
some cells the protein was diffusely distributed (Fig. 2b) while in
others it accumulated in distinct, but as yet uncharacterised,
subnuclear compartments (Fig. 2c). All three subcellular localisa-
tions can be found in cells growing on a single glass coverslip. A
quantitative analysis of the different localisation patterns from
three independent transfection experiments is shown in Table 1.
When p16 was expressed together with p23 as a fusion protein
(p16:p23), it showed an exclusively cytoplasmic staining reminis-
cent of the localisation of p23 alone (Fig. 2d and e). The replication
of positive-sense RNA viruses occurs predominantly in the cyto-
plasm, and thus viral non-structural proteins usually do not
accumulate in the nucleus or have interaction partners in this
compartment. The diffuse nuclear accumulation observed for
RHDV p16 (Fig. 2b) could be explained by the relatively small size
of this protein, which may allow it to enter the nucleus by passive
diffusion if overexpressed in the absence of putative viral inter-
acting partners. The observed aggregation of p16 in distinct sub-
nuclear compartments however (Fig. 2c), may point to a speciﬁc
interaction with nucleic acids and/or cellular proteins. A similar
nuclear/subnuclear accumulation of non-structural proteins has
been reported for Encephalomyocarditis virus, a picornavirus, for
which a nuclear accumulation of the 2A protein and a close
association of this protein with the nucleolar ribosomal chaperone
protein B23 was reported (Aminev et al., 2003). It was suggested
that 2A upregulates the formation of modiﬁed ribosomes with a
preference for viral internal ribosomal entry sites, thereby con-
tributing to the inhibition of cap-dependent cellular mRNA trans-
lation (Aminev et al., 2003). Additional research is needed to
address the question of whether p16 serves a similar or other
functions in the nucleus of infected cells.
The p23 protein showed an endoplasmic reticulum (ER)-like
localisation pattern, including labelling of the nuclear envelope
(Fig. 2d). These ﬁndings are in agreement with previous studies on
other caliciviruses. For example, it has been shown that the
murine norovirus (MNV) equivalent of p23 (NS1-2) and its FCV
homologue (p32) also localise to the ER (Bailey et al., 2010; Hyde
and Mackenzie, 2010). In contrast, the human norovirus equivalent
of p23 (p48) appears to interact with Golgi rather than ER
membranes (Fernandez-Vega et al., 2004). It was suggested that
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Fig. 1. Genomic organisation of RHDV. Virions contain genomic (a) and subge-
nomic (b) RNA. Both RNA species are polyadenylated A(n) at the 30 end and
covalently linked to a genome binding protein (VPg) at the 50 region. The genomic
RNA contains two slightly overlapping open reading frames (ORFs), ORF1 and ORF2.
ORF1 codes for a polyprotein that is proteolytically processed into the major
structural capsid protein VP60 and the non-structural proteins p16, p23, helicase,
p29, VPg, protease and RNA-dependent RNA polymerase (black and white triangles
indicate proven and suspected cleavage sites, respectively). ORF2 encodes the
minor structural protein, VP10. The shorter subgenomic RNA also contains these
two overlapping ORFs, however the ﬁrst ORF lacks the coding sequence of the non-
structural proteins. (From Abrantes et al., 2012 with modiﬁcations).
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the MNV, Norwalk virus and FCV homologues of p23 play a role in
the induction of intracellular membrane rearrangements asso-
ciated with viral replication (Bailey et al., 2010; Fernandez-Vega
et al., 2004; Hyde and Mackenzie, 2010). Since many related
positive-sense RNA viruses use an ER-derived membrane network
for replication (den Boon and Ahlquist, 2010), the observed ER-like
staining pattern of RHDV p23 supports the hypothesis that this
protein may have a similar function. Notably, p23 contains a
sequence element (KKLLKKGKK) close to its N-terminus that
resembles a nuclear localisation signal (NLS). However, a nuclear
accumulation of recombinant p23 was not observed. Treatment of
transfected cells expressing p23 with leptomycin B (10 ng/ml, for
1 h) to speciﬁcally block nuclear export did not cause a signiﬁcant
redistribution of the protein, suggesting that p23 does not shuttle
between the nucleus and cytoplasm (data not shown). When the
putative NLS sequence of p23 (including ﬂanking amino acids) was
fused either C- or N-terminally to green ﬂuorescent protein (GFP),
and resulting fusion proteins were expressed in RK-13 cells, the
resultant subcellular localisation was not signiﬁcantly different
from that of GFP alone (data not shown). Taken together, these
results indicate that the stretch of basic residues in p23 is clearly
not a monopartite NLS. Future studies are needed to determine
whether these basic amino acids play another role in the function
of the p23 protein.
The recombinant RHDV helicase accumulated exclusively in the
cytoplasm of transfected cells, where it tended to aggregate in
distinct but as yet uncharacterised foci (Fig. 2f). Previous studies
on other caliciviruses demonstrated that the FCV homologue of
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Fig. 2. Subcellular localisation of individually expressed recombinant non-structural RHDV proteins. RK-13 cells were transiently transfected with expression constructs
coding for myc-tagged versions of p16 (a–c); p23 (d); p16:p23 (e); 2C-like helicase (f); p29 (g); VPg (h); 3C-like protease (i); and polymerase (j–l). Cells were ﬁxed 24 h after
transfection and recombinant proteins were immunostained using myc-speciﬁc antibodies. Dotted lines indicate the outline of cell nuclei. Percentages indicate frequencies
with which different localisation patterns were found (p16 and polymerase expression were analysed in 636 and 1186 transfected cells, respectively; obtained from three
independent experiments).
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the RHDV helicase (p39) showed an association with ER mem-
branes (Bailey et al., 2010), while the MNV and Norwalk virus
homologues were observed to localise to discrete vesicular struc-
tures of unknown origin in the cytoplasm of the cells (Hyde and
Mackenzie, 2010).
The p29 protein accumulated in the cytoplasm with a tendency
to form a crescent-like pattern at one side of the nucleus (Fig. 2g).
The p29 protein did not associate with the nuclear envelope and
we did not observe a colocalisation with ER membranes. Previous
studies on other caliciviruses, showed that the FCV homologue of
p29 (p30) localised to the ER (Bailey et al., 2010), and that the MNV
homologue (NS4) colocalised with a broad range of membrane
components, including the Golgi apparatus and endosomes (Hyde
and Mackenzie, 2010; Hyde et al., 2009).
RHDV VPg protein did not associate with any distinct structures
within the cell. Instead, the protein was diffusely distributed in
both the cytoplasm and the nucleoplasm (Fig. 2h). VPg was readily
expressed and showed no pronounced cytotoxic effects. This is in
contrast to the MNV homologue, for which individual expression
was not achieved, and it was speculated that the co-expression of
other virus proteins may be required for VPg accumulation (Hyde
and Mackenzie, 2010).
Similar to the VPg protein, the RHDV protease did not associate
with any distinct intracellular structures, and was found to
accumulate in nuclear and cytoplasmic compartments (Fig. 2i).
The expression of the RHDV polymerase revealed various
intracellular localisation patterns. In a large proportion of cells
(30–31% of transfected cells), the protein was diffusely distributed
throughout the cytoplasm and nucleus, and it did not associate with
any identiﬁable cellular structures (Fig. 2j). In another large propor-
tion of cells (45–52%), protein aggregations were observed in
numerous discrete foci distributed throughout the cytoplasm
(Fig. 2k), while in a smaller proportion (17–25%) the polymerase
accumulated in a single cluster adjacent to the nucleus (Fig. 2l). A
quantitative analysis of the different localisation patterns from
three independent transfection experiments is shown in Table 1.
Interestingly, the occurrence of all three staining patterns (i.e.
diffuse cytoplasmic, cytoplasmic aggregates, and as a single cluster)
was only found in RK-13 cells. In human hepatoma (Huh-7) cells,
we did not observe the formation of a large cluster adjacent to the
nucleus, and in African Green monkey kidney (Vero) cells, only a
diffuse staining throughout the cytoplasm and nucleus was
detected (data not shown). The cause of the variability observed
between these cell lines remains unclear. Nevertheless, a diffuse
accumulation within both the cytoplasm and nucleus was common
for all three cell lines tested, and is reminiscent of the intracellular
localisation pattern described for the MNV polymerase (NS7) when
expressed in Vero cells (Hyde and Mackenzie, 2010).
For both the polymerase and p16, we did not observe any
obvious correlation between distinct staining patterns and time
post-transfection. Therefore, the observed differences in localisa-
tion may be a result of different expression levels. For example, it
has been described for certain members of the Flaviviridae family,
such as Dengue virus, Japanese encephalitis virus and West Nile
virus, that overexpressed proteins with strong RNA binding prop-
erties (e.g. core/capsid proteins) can accumulate in the nucleus
(Paul and Bartenschlager, 2013). Alternatively, the differences in
the observed staining patterns for these proteins may be a
consequence of different stages of the cell cycle.
Western blot analysis of each of the myc-tagged RHDV
non-structural proteins was carried out to conﬁrm that expres-
sion constructs produce proteins of the correct size, and that
these recombinant proteins do not undergo major degradation
(Fig. 3).
Cleavage of the p16/p23 junction
Previous in vitro and in vivo studies have revealed that RHDV,
like other caliciviruses, uses a cascade processing strategy to
produce multiple cleavage products from the single polyprotein
encoded by ORF1 (Konig et al., 1998; Martin Alonso et al., 1996;
Meyers et al., 2000; Oka et al., 2011; Wirblich et al., 1995;
Wirblich et al., 1996). However, there are notable differences
between the four major calicivirus genera in managing cleavage
events close to the N-terminus of the polyprotein (Oka et al.,
2011). For example, it was demonstrated for FCV and sapovirus
ORF1 polyproteins that sites equivalent to the RHDV p16/p23
junction are likely cleaved by viral proteases (Oka et al., 2005,
2011, 2006; Sosnovtsev et al., 2002). Conversely, MNV and Nor-
walk virus NS1–2 proteins lack this cleavage site (Blakeney et al.,
2003; Sosnovtsev et al., 2006), although evidence for processing
of the N-terminal site in MNV-infected cells by a cellular protease
(caspase-3) has been reported (Sosnovtsev et al., 2006). RHDV
polyprotein processing has been studied previously; however,
conﬂicting evidence has been reported in relation to N-terminal
cleavage events. In coupled in vitro transcription–translation
Table 1
Quantitative analysis of different intracellular localisations for p16 and polymerase.
p16 localisation pattern
Predominantly
cytoplasmic
Diffuse in
nucleus and
cytoplasm
Nuclear dots
Exp 1 15% (28) 39% (74) 46% (86)a
Exp 2 7% (13) 46% (92) 47% (94)
Exp 3 14% (34) 40% (101) 46% (114)
Polymerase localisation pattern
Diffuse in
nucleus and
cytoplasm
Numerous
discrete foci in
cytoplasm
Cluster
adjacent to
the nucleus
Exp 1 31% (105)a 52% (179) 17% (59)
Exp 2 30% (119) 45% (175) 25% (98)
Exp 3 30% (136) 50% (224) 20% (91)
a Percent of cell with a particular localisation pattern (total number of cells
counted).
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studies of RHDV cDNA constructs, Alonso and co-workers identi-
ﬁed a gene product with a molecular mass of 80 kDa, correspond-
ing to the N-terminus of the polyprotein (Martin Alonso et al.,
1996). In contrast, Wirblich and co-workers showed that in vitro
translation of RHDV RNA resulted in three proteins of 16, 23 and
37 kDa (Wirblich et al., 1996), and similar results were obtained
by Meyers and co-workers after the transient expression of cDNA
constructs (Meyers et al., 2000). However, it should be noted that
these experiments were carried out in either cell-free conditions
or in BHK-21 cells in which the polyprotein was expressed using a
vaccinia virus (MVA-T7) system. An analysis of RHDV protein
expression in infected primary rabbit hepatocytes showed the
presence of a cleavage product corresponding to p16, although
the amount was low (Konig et al., 1998). Collectively, a cleavage
product corresponding to the p16 protein was detected in most
in vitro and in vivo studies; however, it is not entirely clear
whether the extreme N-terminus of the RHDV polyprotein is
cleaved exclusively by the viral protease, by cellular proteases or
by a combination of viral and cellular enzymes.
To better understand the role of the RHDV protease in cleaving
the p16/p23 junction, a p16:p23 fusion protein with a C-terminal
myc tag (p16:p23:myc) was expressed in RK-13 cells either indivi-
dually or together with the viral protease. Cells were lysed 24 h
after transfection and were analysed by Western blot (Fig. 4). When
p16:p23:myc was expressed individually, a band corresponding to
the size of the uncleaved fusion protein was observed (Fig. 4, lane
2). In contrast, when p16:p23:myc was co-expressed with the viral
protease, the original band corresponding to the size of fusion
protein disappeared, and a smaller band corresponding to the size
of the p23:myc protein was detected (Fig. 4, lane 3). These
observations support the hypothesis that cleavage at the p16/p23
junction is mediated by the RHDV 3C-like protease. Furthermore,
our results demonstrate that the RHDV protease can cleave the p16/
p23 junction in trans, and does not require the context of a nascent
polyprotein. This is in contrast to the proteolytic processing
mechanisms reported for Hepatitis C virus (HCV) and other ﬂavi-
viruses, where viral proteinases require other viral proteins or
protein domains as cofactors (e.g. the HCV NS2–3 protease and
the NS3/4 proteinase complex) (discussed in Bartenschlager et al.,
2004). The detection of faint bands corresponding to the size of
p23:myc protein, or alternatively degradation products in cells
expressing p16:p23:myc without the viral protease, may also
indicate that the p16:p23 fusion protein is partially cleaved by the
cellular proteases (Fig. 4, lane 2).
Oligomerisation of p23
The non-structural protein p23 shows no signiﬁcant sequence
similarity to other viral or cellular proteins, and very little is
known about its function and role in the RHDV lifecycle. Previous
studies on the MNV equivalent of a p16:p23 fusion protein (NS1–
2) revealed that NS1–2 forms homodimers when recombinant
proteins were expressed in both bacteria and transfected mam-
malian cells (Baker et al., 2012). This observation prompted us to
investigate the capability of the RHDV p23 protein to form
oligomers by conducting a nuclear co-translocation assay and
cross-linking experiments.
Protein co-translocation assays exploit the ability of proteins to
co-translocate interaction partners to new intracellular compart-
ments. Ponten and co-workers were the ﬁrst to fuse a foreign NLS to
a cytoplasmic protein (in this case, human MxA) to analyse a
protein-protein interaction. When NLS:MxA fusion proteins
were co-expressed with normal MxA proteins, both proteins
accumulated in the nucleus, demonstrating oligomerisation
under physiological conditions (Ponten et al., 1997). Similarly,
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Fig. 3. Western blot analysis of individually expressed recombinant non-structural RHDV proteins. RK-13 cells were transiently transfected with expression constructs
coding for myc-tagged versions of p16 (a); p23 (b); 2C-like helicase (c); p29 (d); VPg (e); 3C-like protease (f); and polymerase (g). Cells were lysed 24 h after transfection and
analysed using myc-tag and actin-speciﬁc antibodies.
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Fig. 4. Protease-mediated cleavage of the p16:p23 fusion protein. RK-13 cells were
transfected/co-transfected with expression constructs coding for p23:myc (lane 1),
p16:p23:myc (lane 2), p16:p23:myc together with the myc-tagged RHDV 3C-like
protease (lane 3), the myc-tagged 3C-like protease alone (lane 4) or left untrans-
fected (lane 5). Cells were lysed 24 h after transfection and protein samples were
analysed by Western blot using myc-speciﬁc antibodies. The appearance of a short
protein fragment corresponding to p23:myc in cells expressing a p16:p23:myc
fusion protein together with the viral protease (lane 3) indicates that the 3C-like
protease cleaves at the p16/p23 junction.
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we expressed a myc-tagged p23 protein (p23:myc) that showed
cytoplasmic localisation as expected (Fig. 5a and b) and generated a
p23 fusion protein containing a foreign NLS along with an N-
terminal ﬂag-tag (ﬂag:NLS:p23). When transiently expressed,
ﬂag:NLS:p23 accumulated in the cell nucleus (Fig. 5c and d).
However, when ﬂag:NLS:p23 was co-expressed with a myc-tagged,
but otherwise unaltered p23 protein, the myc-tagged p23 protein
was transported from the cytoplasm into the nucleus, suggesting an
oligomerisation between p23:myc and ﬂag:NLS:p23 (Fig. 5e–h).
To conﬁrm this observation, a chemical cross-linking experi-
ment was performed (Fig. 6). Cells expressing myc-tagged p23
were treated with formaldehyde as a cross-linker and lysed. When
samples treated with the cross-linker were analysed by Western
blot, a higher molecular mass band corresponding to the predicted
size of a p23 dimer was detected (Fig. 6, lane 2).
Together, these results point to a dimerisation of p23 in
transfected cells. Interestingly, in one out of four independent
cross-linking experiments, we observed an additional, larger band
with a molecular mass of approximately 100 kDa (data not
shown). The appearance of this band may be attributed to further
p23 oligomerisation or alternatively to an interaction of p23 with
cellular proteins.
p2
3:
m
yc
fla
g:
N
LS
:p
23
p2
3:
m
yc
fla
g:
N
LS
:p
23
Wild-type p23 in 
the cytoplasm
Nuclear targeting 
of NLS:p23
Nuclear co-translocation of wild-type 
p23 and NLS:p23
anti-myc
anti-flag
anti-myc anti-flag overlay
Fig. 5. Nuclear co-translocation assay reveals p23 oligomerisation. RK-13 cells were transfected with expression constructs for a myc-tagged but otherwise unaltered p23:
myc fusion protein (a and b), a ﬂag-tagged p23 with an artiﬁcially added nuclear localisation signal (ﬂag:NLS:p23) (c and d) or a combination of these expression constructs
(e–g). Cells were ﬁxed after 24 h and immunostained with myc- and/or ﬂag-speciﬁc antibodies. Myc-tagged p23 accumulated in the cytoplasmwhen expressed individually,
while ﬂag:NLS:p23 appeared in the cell nucleus. Co-expression of myc-tagged p23 and ﬂag:NLS:p23 resulted in the translocation of myc-tagged p23 to the nucleus and the
co-localisation of p23:myc and ﬂag:NLS:p23 in the nucleus (e–g), suggesting an oligomerisation of p23 proteins (as depicted in b, d and h).
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Fig. 6. Biochemical evidence for p23 dimerisation. RK-13 cells were transfected
with an expression construct coding for a myc-tagged version of the p23 protein
(lanes 1 and 2) or left untransfected (lane 3 and 4). Cells were treated with
formaldehyde (lane 2 and 4) to induce cross-linking 24 h after transfection. Cells
were then lysed and protein samples were analysed by Western blot using myc-
speciﬁc antibodies. The appearance of a larger band corresponding to the size of a
putative p23 dimer after cross-linking (lane 2) suggests p23 dimerisation.
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Redistribution of Golgi membranes in cells expressing the viral
polymerase
Double immunoﬂuorescence staining of cells expressing the
recombinant (myc-tagged) RHDV polymerase revealed a striking
redistribution of Golgi membranes 24 h after transfection (Fig. 7).
Antibodies speciﬁc for the myc-tag and for giantin were used to
simultaneously stain the polymerase and Golgi membranes,
respectively. However, an overlay of signals did not reveal a
signiﬁcant co-localisation of the polymerase and giantin (Fig. 7d,
h and l). The effect of the RHDV polymerase on Golgi morphology
in transfected cells appears to be cell line- and species-indepen-
dent, as the same phenomenon was observed in three different
cell lines, namely rabbit RK-13 cells (Fig. 7a–d), monkey Vero cells
(Fig. 7e–h) and human Huh-7 cells (Fig. 7i–l). To exclude the
possibility that the observed effect was an artefact created by an
immunotagged protein overexpressed out of context, cells were
transfected with a construct that encodes the entire RHDV poly-
protein. In this experiment, none of the viral proteins were
immunotagged, and transfected cells were visualised through
staining of the VP60 protein. VP60 is the most C-terminal protein
of the ORF1 polyprotein, and can thus be used as a marker for the
expression of all other RHDV proteins, including the polymerase.
In accordance with the results obtained with recombinant poly-
merase expressed individually, we found that Golgi membranes
were also redistributed in cells expressing the entire RHDV
polyprotein (Fig. 8), suggesting that the observed redistribution
of Golgi membranes was due to the speciﬁc activity of the RHDV
polymerase.
The replication of many positive-strand RNA viruses is asso-
ciated with extensive rearrangements of host cell membranes and
the formation of membranous organelle-like structures within the
cytoplasm of infected cells (reviewed in (den Boon and Ahlquist,
2010; den Boon et al., 2010; Paul and Bartenschlager, 2013)). For
example, Poliovirus reorganises Golgi, ER and lysosomes in
infected cells (Schlegel et al., 1996). Notably, individual expression
of poliovirus 2BC or 2C proteins was sufﬁcient for the induction of
membrane changes similar to that in infected cells (Cho et al.,
1994). Coxsackievirus B3 also rearranges Golgi membranes via a
mechanism involving the 3A protein (Cornell et al., 2006), and
similar observations were reported for the Human rhinovirus 1A
and 16 (Mousnier et al., 2014; Quiner and Jackson, 2010). Kunjin
virus, a member of the Flaviviridae family, also utilises trans-Golgi
membranes and membranes of the intermediate compartment to
generate vesicles that were found to be associated with viral RNA
replication in infected cells (Mackenzie et al., 1999). In MNV-
infected cells, replication complexes are associated with mem-
branes derived from the ER, the trans-Golgi apparatus and endo-
somes (Hyde et al., 2009; Wobus et al., 2004), although the Golgi
body remains intact (Hyde et al., 2009). However, expression of
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normal Golgi structure in untransfected control cells (a, e and i). However, an overlay of polymerase- and Golgi-speciﬁc signals did not reveal a co-localisation of the
polymerase and giantin (d, h and l).
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the MNV NS4 protein alone is associated with a partial dispersion
of the Golgi apparatus (Hyde and Mackenzie, 2010).
Although our ﬁndings are generally in agreement with previous
studies in which one or a few viral non-structural proteins were
identiﬁed to be responsible for the formation of membranous
organelle-like structures in the host cell, it should be noted that
most mechanisms of virus-induced membrane reorganisation
described to date are attributed to viral proteins other than the
polymerase (den Boon and Ahlquist, 2010; Paul and Bartenschlager,
2013). Nevertheless, a few cases of polymerase-dependent mem-
brane rearrangements have also been described (Kopek et al., 2010).
For example, in cells infected with Flock House virus, a member of
the Nodaviridae family, the multifunctional viral replicase protein A
plays a key role in the formation of vesicles derived from the outer
mitochondrial membrane, and in the assembly of replication com-
plexes inside these structures (Kopek et al., 2010; Miller and
Ahlquist, 2002; Miller et al., 2001). Expression of the polymerase
of Nodamura virus, also a nodavirus, induced mitochondria to
cluster into distinct cytoplasmic networks. It was shown that
nodavirus RNA synthesis localises to these polymerase-induced
mitochondrial networks, establishing the polymerase as a key
protein for the assembly of membrane-anchored replication com-
plexes (Gant et al., 2014). Our unexpected ﬁnding of a redistribution
of Golgi membranes in cells expressing the RHDV polymerase, or
the entire virus polyprotein, strongly indicates that RHDV employs
the polymerase to utilise modiﬁed membranes of the secretory
pathway for its replication.
Conclusions
This study is the ﬁrst to describe the intracellular localisation of
individually expressed RHDV non-structural proteins, and as such is
an important step towards increasing our understanding of the
molecular biology of this extraordinarily virulent virus. It is feasible
that the subcellular localisation of the individual viral proteins may
change when they are expressed in the context of the viral
polyprotein, as reported for MNV (Herod et al., 2014; Hyde et al.,
2012, 2009). However, such experiments require a set of protein-
speciﬁc antibodies and thus will be the subject of future studies.
Importantly, intracellular localisation of individually expressed
proteins and even proteolytic cleavage of the ﬁrst two non-
structural proteins varied from those observed for the homologues
of other caliciviruses. This indicates a high level of variation in the
intracellular replication mechanisms within the Caliciviridae, and
clearly warrants the investigation of each member of this virus
family in its own right. The observed redistribution of Golgi
membranes in cells expressing the RHDV polymerase or the entire
polyprotein supports the hypothesis that, similar to many other
positive-sense RNA viruses, RHDV may use membranes of the
secretory pathway for replication. Our ﬁnding that expression of
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the RHDV polymerase alone can induce disruption of the structural
integrity of the Golgi suggests that this protein may play a key role
in the establishment of replication complexes beyond its obvious
role as the RNA-dependent RNA polymerase. More studies are
clearly needed to further unravel details of the unique mechanisms
of replication and host cell membrane rearrangements in this highly
virulent pathogen of rabbits.
Methods
Cells
Rabbit kidney (RK-13) and African green monkey kidney (Vero)
cells (obtained from European Collection of Cell Cultures) were
grown in Eagle's minimal essential medium (EMEM, Sigma-
Aldrich) supplemented with 10% foetal bovine serum (Sigma-
Aldrich), 2 mM Glutamax (Gibco), 100 mg/ml of streptomycin
(Gibco) and 100 units/ml of penicillin (Gibco). Human hepatoma
(Huh-7) cells (kindly provided by Dr Nadia Warner, Victorian
Infectious Diseases Reference Laboratory, Melbourne, Australia)
were grown in Dulbecco's Modiﬁed Eagle Medium (DMEM) high
glucose (Sigma-Aldrich), supplemented with 10% foetal bovine
serum (Sigma-Aldrich), 100 mg/ml of streptomycin (Gibco) and 100
units/ml of penicillin (Gibco).
Plasmids
RHDV RNA was puriﬁed from a commercial RHDV suspension
(Czech strain V351) (Elizabeth Macarthur Agricultural Institute,
Menangle, Australia) using the RNeasy Mini Kit (Qiagen). Viral RNA
was reverse transcribed using SuperScript III reverse transcriptase
(Life Technologies). The cDNAs encoding individual non-structural
proteins were ampliﬁed using Platinum Taq DNA polymerase (Life
Technologies) and gene-speciﬁc primers (Sigma-Aldrich; for
sequence information, see Table 2). Primers contained either
BamHI (forward) and HindIII (reverse) restriction sites (for the
ampliﬁcation of p16, p23, the 2C-like helicase, the 3C-like pro-
tease, VPg and the p16:p23 fusion protein) or NotI (forward) and
BamHI (reverse) restriction sites (for p29 and the polymerase).
Resulting amplicons were cloned into the pcDNA3.1/myc-His(-) C
expression vector (Life Technologies) to generate a series of fusion
proteins with a C-terminal myc:his tag.
To generate a ﬂag-tagged p23 fusion protein with an artiﬁcial
nuclear localisation signal (NLS), the p23 coding sequence was
ampliﬁed as described above, using gene-speciﬁc primers (Sigma-
Aldrich) that contain sequences coding for a BamHI restriction site
and the SV40 large T antigen NLS (PKKKRKV) (forward) or a HindIII
restriction site (reverse) (Table 2). Resulting amplicons were
cloned into the pCMV-Tag2C expression vector (Agilent Technol-
ogies) to generate a p23 protein with ﬂag tag and artiﬁcial NLS on
the N-terminus (ﬂag:NLS:p23).
The integrity of all newly generated constructs was veriﬁed by
sequencing at the ACRF Biomolecular Resource Facility of the
Australian National University (Canberra, Australia).
For the expression of the RHDV ORF1 polyprotein, the whole
virus genome was cloned into the eukaryotic expression plasmid
pEGFP-N1 (Clontech). Brieﬂy, the genome was ampliﬁed in two
fragments. The ﬁrst fragment of approximately 5.3 kb was ampliﬁed
with primers RHDV-long-fw-BamHI and RHDV-long-rev-NotI-PvuI
(Table 2) and comprised the non-structural proteins with the
exception of the last 50 nucleotides of the polymerase coding
sequence (note, that the PvuI site in the reverse primer introduced
a silent mutation into the polymerase gene, GCA-GCC). The ﬁrst
fragment was then cloned into pEGFP-N1 using the BamHI and NotI
restriction sites, replacing the EGFP sequence. Next, the remaining
part of the genome, including the VP60 coding sequence and the
entire ORF2, was ampliﬁed with primers RHDV-short-fw-PvuI and
RHDV-short-rev-NotI-polyA (Table 2), and the amplicon was incor-
porated into the construct using the PvuI and NotI sites. Both
fragments were ampliﬁed using the Clontech Advantage2 PCR kit
according to manufacturer's instructions.
Table 2
Sequences of primer pairs for generation of expression constructs.
Vector backbone/construct name Primer sequence (50-30)
pcDNA3.1/myc-His(-)
p16:myc F:ATCGTTATAGGATCCTAGCCACCATGGCGGCTATGTCGCG
R:ATCGTCATCAAGCTTC TTCAAAAATAGGGGTGGGAAAAC
p23:myc F: ATCGTTATAGGATCCTAGCCACCATGGGGGAGGTTGACGACTTATTTGTTG
R:ATCGTCATCAAGCTTCCTCAAATGTGTCAAACAGCCTCTTG
Helicase:myc F:ATCGTTATAGGATCCTAGCCACCATGGACTCCGTCCCCACG
R:ATCGTCATCAAGCTTCCTCGAATGAGGCCACG
p29:myc F:ATCGTTATAGCGGCCGCCTGCAGTAGCCACCATGGGTGCCAACAAATTTAACTTTG
R:ATCGTCATCGGATCCAGATATCCTGAAAAGCTTTCGTTGCAAC
VPg:myc F:ATCGTTATAGGATCCTAGCCACCATGGGCGTGAAAGGCAAGAC
R:ATCGTCATCAAGCTTCCTCATAGTCATTGTCATAAAAGCCAC
Protease:myc F: ATCGTCATCGGATCCTAGCCACCATGGGTTTACCTGGGTTCATGAGAC
R:ATCGTCATCAAGCTTCTTCATAAACTCCCTTTGTAATGGTG
Polymerase:myc F:ATCGTTATAGCGGCCGCCTGCAGTAGCCACCATGACGTCAAACTTCTTCTGTGG
R:ATCGTCATCGGATCCAGATATCCTCCATAACATTCACAAATTCGTC
p16:p23:myc F:ATCGTTATAGGATCCTAGCCACCATGGCGGCTATGTCGCG
R:ATCGTCATCAAGCTTCCTCAAATGTGTCAAACAGCCTCTTG
pCMV-Tag2C
ﬂag:NLS:p23 F:ATCGTTATAGGATCCTAGCCACCATGCCCAAGAAAAAGCGCAAGGTCGGGGAGGTTGACGACTTATTTGTTG
R:ATCGTCATCAAGCTTCCTCAAATGTGTCAAACAGCCTCTTG
pEGFP-N1
pEGFP-RHDV(ORF1) F:RHDV-long-fw-BamHI: AAAGGATCCGTGAAAGTTATGGCGGCTATGTCG
R:RHDV-long-rev-NotI-PvuI: AAGCGGCCGCACGATCgGCGCAAGTATCTTCCTAGCAGCATCG
F:RHDV-short-fw-PvuI: TGCcGATCGTAAGAGAGTCGTCTCGGTAGTACC
R:RHDV-short-rev-NotI-polyA: AAAGCGGCCGCT(29)ATAGCTTACTTTAAACTATAAACCCAATTAAACC
The RHDV Czech strain V351 genome sequence (Elsworth et al., 2014) (GenBank accession number: KF594473.1) was used to design primers
for PCR ampliﬁcation.
F - forward primer; R - reverse primer. Restriction sites are underlined. NLS sequence is in bold.
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Antibodies
Monoclonal mouse anti-myc (M4439), polyclonal rabbit anti-myc
(C3956) and monoclonal rat anti-ﬂag antibodies (SAB4200071) were
purchased from Sigma-Aldrich. Polyclonal rabbit anti-giantin anti-
bodies (ab42586) were purchased from Abcam. Monoclonal mouse
anti-actin antibodies (MAB1501) were purchased from Chemicon
International Inc. Goat anti-mouse IgG AlexaFluor 555 (A-21424) and
goat anti-rat IgG AlexaFluor 555 antibodies (A-21434) were pur-
chased from Life Technologies. Goat anti-rabbit IgG DyLight 488
antibodies (GTX76757) were purchased from GeneTex Inc. Goat anti-
mouse IgG H &L (HRP) (ab6789) were purchased from Abcam.
The VP60-speciﬁc monoclonal mouse antibody mab 13C10 was
produced by the Monoclonal Antibody Facility of the Institute for
Medical Research (Perth, Australia) according to standard proto-
cols, using RHDV virus-like particles (Liu et al., 2012) as antigen.
The antibodies were puriﬁed from hybridoma cell culture super-
natants using a protein A antibody puriﬁcation kit (Sigma-Aldrich).
Mab 13C10 detects full length RHDV VP60 in Western blot,
immunoﬂuorescence and ELISA, but not bacterially expressed P1/
P2 domain of VP60 (data not shown), and therefore likely binds in
the inner shell domain of the VP60 protein.
Immunoﬂuorescence
Cells grown on glass coverslips were transfected with expres-
sion constructs using Lipofectamine 2000 or Lipofectamine 3000
(Life Technologies) and incubated for speciﬁed periods of time.
Cells were ﬁxed with 2.5% formaldehyde (Polysciences Inc.) in
phosphate-buffered saline (PBS) for 15 min, permeabilised with
0.25% Triton X-100 in PBS for 15 min, washed in PBS and incubated
for 1 h with blocking solution containing 5% foetal bovine serum
(Sigma-Aldrich) or bovine serum albumin (BSA) (Sigma-Aldrich) in
PBS. All incubations were carried out at room temperature.
Primary and secondary antibodies were diluted in blocking solu-
tion and were incubated for 1 h and 30 min, respectively. Cell
nuclei were stained with 40,6-diamidino-2-phenylindole (DAPI)
(Sigma-Aldrich). After a ﬁnal wash, coverslips were drained and
mounted onto glass slides with Fluoromount aqueous mounting
medium (Sigma-Aldrich). Images were acquired on a Leica SP2 or a
Nikon Ti Eclipse confocal laser-scanning microscope equipped
with 60 objectives (confocal images were collected using a
pinhole aperture setting around 1 Airy Unit). Images were ana-
lysed using ImageJ software (Schneider et al., 2012).
Western blot
Cell lysates were cleared by centrifugation, mixed with SDS-
PAGE sample buffer, denatured by boiling for 5 min and separated
on 8–16% or 4–20% precast Tris–HEPES polyacrylamide gels
(NuSep). Proteins were transferred to a Hybond-C Extra nitrocel-
lulose membrane (Amersham, GE Healthcare) or a Polyscreen
polyvinylidene ﬂuoride (PVDF) transfer membrane (Perkin Elmer)
using a semi-dry blotting module according to the manufacturers'
directions. In some experiments, membranes were temporarily
stained for proteins using 0.1% (w/v) Ponceau S (Sigma-Aldrich) in
5% (v/v) acetic acid (Chem-Supply). The stain was removed by
continued washing in Tris-buffered saline (TBS) containing 0.1%
Tween-20 before membranes were re-activated with methanol
(where appropriate) and blocked with 5% skim milk powder in TBS
containing 0.1% Tween-20 at room temperature. Incubation with
primary antibodies was performed overnight at 4 1C. Incubation
with appropriate secondary antibodies conjugated to horseradish
peroxidise was performed for 1 h at room temperature. SIGMA-
FAST 3,30-diaminobenzidine tablets (Sigma-Aldrich) were used to
visualise protein bands according to manufacturer's instructions.
The resulting images were digitally scanned and processed using
ImageJ software (Schneider et al., 2012). Staining of actin was used
as a loading control. Because of the similar size of actin and some
RHDV proteins (e.g. helicase:myc and p16:p23:myc), where neces-
sary, two gels/membranes were loaded and processed in parallel.
In these cases, one membrane was probed with anti-myc anti-
bodies and the other one with anti-actin antibodies, and the
resulting pictures were collated.
Cross-linking
Chemical cross-linking was performed using formaldehyde, as
described previously (Klockenbusch and Kast, 2010) with modiﬁ-
cations. At 24 h post-transfection, medium was removed from RK-
13 cells, and cells were washed with PBS. Cross-linking was
obtained by incubating cells with 2.5% formaldehyde (Polysciences
Inc.) in PBS for 10 min at room temperature. The reaction was
quenched with 1.25 M glycine in PBS for an additional 10 min at
room temperature. Cells were lysed in lysis buffer containing
25 mM Tris–HCl pH 7.5, 137 mM sodium chloride, 10% glycerol,
0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100 and cOm-
plete Protease Inhibitor Cocktail (Roche). The lysate was mixed
with SDS-PAGE sample buffer, incubated at 65 1C for 5 min and
analysed by Western blot as described above.
Cell counting
Cells transfected with expression constructs coding for myc-
tagged versions of p16 and polymerase were stained as described
above and examined using a Nikon Eclipse Ti–U ﬂuorescence
microscope equipped with a 20 objective. Cells were counted
in at least 20 view ﬁelds from three independent experiments.
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